Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production
Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clin...
Saved in:
Published in | Cell death & disease Vol. 15; no. 9; pp. 688 - 14 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
20.09.2024
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells. We found that a high tumor-stroma ratio was significantly associated with a larger tumor size and higher T stage, pathological grade, number of vascular invasions, and poor overall survival. MSCs in TME promoted the ability of bladder cancer cells to proliferate, migrate, and invade in vitro and in vivo. Next, we demonstrated that MSCs enhance mitochondrial autophagy and mitochondrial biogenesis of bladder cancer cells, and increase energy production, thereby promoting bladder cancer cell progression. Kynurenine (Kyn) produced by MSCs could enhance mitochondrial function by activating the AMPK pathway. IDO1 inhibitor could reverse the tumor‑promoting effects of MSCs in vitro and in vivo. Our results demonstrated that tryptophan metabolites Kyn of MSCs in TME could enhance mitochondrial function by activating the AMPK pathway, thereby promoting bladder cancer cell progression. |
---|---|
AbstractList | Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells. We found that a high tumor-stroma ratio was significantly associated with a larger tumor size and higher T stage, pathological grade, number of vascular invasions, and poor overall survival. MSCs in TME promoted the ability of bladder cancer cells to proliferate, migrate, and invade in vitro and in vivo. Next, we demonstrated that MSCs enhance mitochondrial autophagy and mitochondrial biogenesis of bladder cancer cells, and increase energy production, thereby promoting bladder cancer cell progression. Kynurenine (Kyn) produced by MSCs could enhance mitochondrial function by activating the AMPK pathway. IDO1 inhibitor could reverse the tumor‑promoting effects of MSCs in vitro and in vivo. Our results demonstrated that tryptophan metabolites Kyn of MSCs in TME could enhance mitochondrial function by activating the AMPK pathway, thereby promoting bladder cancer cell progression. Abstract Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells. We found that a high tumor-stroma ratio was significantly associated with a larger tumor size and higher T stage, pathological grade, number of vascular invasions, and poor overall survival. MSCs in TME promoted the ability of bladder cancer cells to proliferate, migrate, and invade in vitro and in vivo. Next, we demonstrated that MSCs enhance mitochondrial autophagy and mitochondrial biogenesis of bladder cancer cells, and increase energy production, thereby promoting bladder cancer cell progression. Kynurenine (Kyn) produced by MSCs could enhance mitochondrial function by activating the AMPK pathway. IDO1 inhibitor could reverse the tumor‑promoting effects of MSCs in vitro and in vivo. Our results demonstrated that tryptophan metabolites Kyn of MSCs in TME could enhance mitochondrial function by activating the AMPK pathway, thereby promoting bladder cancer cell progression. Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells. We found that a high tumor-stroma ratio was significantly associated with a larger tumor size and higher T stage, pathological grade, number of vascular invasions, and poor overall survival. MSCs in TME promoted the ability of bladder cancer cells to proliferate, migrate, and invade in vitro and in vivo. Next, we demonstrated that MSCs enhance mitochondrial autophagy and mitochondrial biogenesis of bladder cancer cells, and increase energy production, thereby promoting bladder cancer cell progression. Kynurenine (Kyn) produced by MSCs could enhance mitochondrial function by activating the AMPK pathway. IDO1 inhibitor could reverse the tumor‑promoting effects of MSCs in vitro and in vivo. Our results demonstrated that tryptophan metabolites Kyn of MSCs in TME could enhance mitochondrial function by activating the AMPK pathway, thereby promoting bladder cancer cell progression.Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism of MSCs on bladder cancer are uncertain. Here we analyzed 205 patient samples to explore the relationships between tumor-stroma ratio and clinicopathological features. A co-culture model and nude mouse transplantation were used to explore the biological roles and molecular mechanisms of MSCs on bladder cancer cells. We found that a high tumor-stroma ratio was significantly associated with a larger tumor size and higher T stage, pathological grade, number of vascular invasions, and poor overall survival. MSCs in TME promoted the ability of bladder cancer cells to proliferate, migrate, and invade in vitro and in vivo. Next, we demonstrated that MSCs enhance mitochondrial autophagy and mitochondrial biogenesis of bladder cancer cells, and increase energy production, thereby promoting bladder cancer cell progression. Kynurenine (Kyn) produced by MSCs could enhance mitochondrial function by activating the AMPK pathway. IDO1 inhibitor could reverse the tumor‑promoting effects of MSCs in vitro and in vivo. Our results demonstrated that tryptophan metabolites Kyn of MSCs in TME could enhance mitochondrial function by activating the AMPK pathway, thereby promoting bladder cancer cell progression. |
ArticleNumber | 688 |
Author | Tian, Junqiang Yang, Enguang Jing, Suoshi Wang, Zhiping Golijanin, Dragan J. Wang, Hanzhang Yang, Li Fu, Shengjun Wang, Fang El-Deiry, Wafik S. Cheng, Liang |
Author_xml | – sequence: 1 givenname: Enguang surname: Yang fullname: Yang, Enguang organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center – sequence: 2 givenname: Suoshi surname: Jing fullname: Jing, Suoshi organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center – sequence: 3 givenname: Fang surname: Wang fullname: Wang, Fang organization: Medical experiment center, Lanzhou University – sequence: 4 givenname: Hanzhang surname: Wang fullname: Wang, Hanzhang organization: The Legorreta Cancer Center at Brown University, Department of Pathology and Laboratory Medicine, The Warren Albert Medical School of Brown University, Brown University Health – sequence: 5 givenname: Shengjun surname: Fu fullname: Fu, Shengjun organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center – sequence: 6 givenname: Li surname: Yang fullname: Yang, Li organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center – sequence: 7 givenname: Junqiang surname: Tian fullname: Tian, Junqiang organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center – sequence: 8 givenname: Dragan J. surname: Golijanin fullname: Golijanin, Dragan J. organization: Division of Urology, Department of Surgery, The Warren Albert Medical School of Brown University, The Miriam Hospital – sequence: 9 givenname: Wafik S. orcidid: 0000-0002-9577-8266 surname: El-Deiry fullname: El-Deiry, Wafik S. organization: The Legorreta Cancer Center at Brown University, Department of Pathology and Laboratory Medicine, The Warren Albert Medical School of Brown University, Brown University Health – sequence: 10 givenname: Liang orcidid: 0000-0001-6049-5293 surname: Cheng fullname: Cheng, Liang email: liang_cheng@brown.edu organization: The Legorreta Cancer Center at Brown University, Department of Pathology and Laboratory Medicine, The Warren Albert Medical School of Brown University, Brown University Health, Division of Urology, Department of Surgery, The Warren Albert Medical School of Brown University, The Miriam Hospital – sequence: 11 givenname: Zhiping orcidid: 0000-0002-8140-591X surname: Wang fullname: Wang, Zhiping email: wangzplzu@163.com organization: Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Urological Clinical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39304650$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAUhSNUREvpC7BAkdiwCdjxPxtUVfxUKmIDa8uxbzIeJfZgJyPNO_DQeGZaaLuoN7aS8x0f-dyX1UmIAarqNUbvMSLyQ6aYYtWgljZIIC4b9aw6axHFDZVSndw7n1YXOa9RWYSglvEX1SlRBFHO0Fn15ztkCHa1m8xY5xmm2sI45tqHel6mmOrJ2xQhbH2KYYIwf6xd8ltIuY593Y3GOUi1NcGWbZPikCBnHwu9SnEZVoWfo13FUKhyg9sFUxxzbYKrIUAadnvKLXYu0KvqeW_GDBe3-3n168vnn1ffmpsfX6-vLm8ayyieG8dZR3oMApEOWiF4rzBHzHJpEbXKdsAt6luHJDMEHBVKtUQZ0lHWtYApOa-uj74umrXeJD-ZtNPReH34ENOgTZq9HUHbFqx0UlgkMe2ZkMYg2QmKmQSGuSlen45em6WbwNnyRMmMD0wf_gl-pYe41bj0x6jap3l365Di7wXyrCef9y2YAHHJmmAkGOK8lUX69pF0HZcUylsdVAQrIUVRvbkf6V-Wu9aLQB4FpdqcE_Ta-tnsGygJ_agx0vsZ08cZ02XG9GHGtCpo-wi9c38SIkcoF3EYIP2P_QT1F8845rM |
CitedBy_id | crossref_primary_10_1016_j_tranon_2025_102349 crossref_primary_10_1016_j_ijbiomac_2025_139777 crossref_primary_10_1021_acs_jmedchem_4c02116 crossref_primary_10_1039_D4NR05306K crossref_primary_10_1155_sci_6064671 |
Cites_doi | 10.3233/CBM-2009-0115 10.3322/caac.21670 10.1016/j.jhazmat.2021.126082 10.1038/s41573-019-0016-5 10.3389/fonc.2017.00081 10.1038/s41592-019-0638-x 10.1021/pr4000448 10.1038/nature07813 10.1002/jnr.24042 10.1038/s41568-020-00313-1 10.1038/s41585-022-00608-y 10.1038/cr.2017.155 10.1038/s42255-020-00317-z 10.1155/2023/7059289 10.1016/j.bbadis.2023.166746 10.1016/j.semcancer.2019.06.003 10.1016/j.cell.2016.07.002 10.1016/j.ccr.2012.02.014 10.1016/S0140-6736(20)30230-0 10.1038/nrd.2016.193 10.1371/journal.pone.0115870 10.1038/nrc3846 10.1038/nrm.2017.95 10.1016/j.cca.2018.01.039 10.1111/bju.15205 10.1073/pnas.0705070104 10.1158/0008-5472.CAN-17-2285 10.3322/caac.21631 10.1158/0008-5472.CAN-13-1656 10.1136/bmj-2023-076743 10.1084/jem.20130066 10.1038/nature10491 10.4049/jimmunol.0903670 10.1038/ncomms3612 10.1016/j.aca.2018.02.026 10.1016/j.cell.2011.02.013 10.1186/s13059-017-1349-1 10.1042/EBC20170104 10.1124/pharmrev.120.000086 10.3389/fendo.2021.699732 10.1021/pr901173v 10.3390/biom10020347 10.1200/JCO.2019.37.7_suppl.358 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41419-024-07068-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-4889 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_c2ec8d87c0814f578aa08b74158e516a PMC11415494 39304650 10_1038_s41419_024_07068_9 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82060459 funderid: https://doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82060459 |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PQGLB 7XB 8FK AARCD K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c541t-d65b3f1e703be2776f91605c68c04c9cbe6c0f2d085a3ed4799239a3b45b2e143 |
IEDL.DBID | M48 |
ISSN | 2041-4889 |
IngestDate | Wed Aug 27 01:32:04 EDT 2025 Thu Aug 21 18:34:21 EDT 2025 Fri Jul 11 11:03:34 EDT 2025 Wed Aug 13 08:43:56 EDT 2025 Mon Jul 21 06:06:07 EDT 2025 Tue Jul 01 03:50:17 EDT 2025 Thu Apr 24 23:07:17 EDT 2025 Fri Feb 21 02:38:21 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-d65b3f1e703be2776f91605c68c04c9cbe6c0f2d085a3ed4799239a3b45b2e143 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9577-8266 0000-0001-6049-5293 0000-0002-8140-591X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-024-07068-9 |
PMID | 39304650 |
PQID | 3107319787 |
PQPubID | 2041963 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c2ec8d87c0814f578aa08b74158e516a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11415494 proquest_miscellaneous_3107506628 proquest_journals_3107319787 pubmed_primary_39304650 crossref_citationtrail_10_1038_s41419_024_07068_9 crossref_primary_10_1038_s41419_024_07068_9 springer_journals_10_1038_s41419_024_07068_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-09-20 |
PublicationDateYYYYMMDD | 2024-09-20 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2024 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Lopez-Beltran, Cookson, Guercio, Cheng (CR3) 2024; 384 Shi, Du, Lin, Wang (CR7) 2017; 16 Timaner, Tsai, Shaked (CR6) 2020; 60 Li, Hou, Hao (CR29) 2017; 95 Ward, Thompson (CR30) 2012; 21 Wittmann, Stirdivant, Mitchell, Wulff, McDunn, Li (CR39) 2014; 9 Holmgaard, Zamarin, Munn, Wolchok, Allison (CR44) 2013; 210 Lee, Mahendran, Tham, Thamboo, Chionh, Lim (CR35) 2021; 127 Prendergast, Malachowski, DuHadaway, Muller (CR43) 2017; 77 Chen, Zhong, Zhou, Zhang (CR18) 2018; 1037 Lin, Xu, Li (CR9) 2019; 19 Lee, Lam, Rosser, Theodorescu, Parks, Chan (CR4) 2022; 19 Srivastava, Roy, Singh, Kumar, Dalela, Sankhwar (CR40) 2010; 6 Zaccolo, Zerio, Lobo (CR21) 2021; 73 Platten, Nollen, Röhrig, Fallarino, Opitz (CR24) 2019; 18 Lu, Tao (CR33) 2021; 12 Galsky, Arija, Bamias, Davis, De Santis, Kikuchi (CR2) 2020; 395 Zhang, Feng, Wang, Quan, Yu, Tao (CR19) 2021; 417 Babar, Saeed, Tabish, Sarwar, Thorat (CR25) 2023; 1869 Patel, Oh, Galsky (CR1) 2020; 70 Herzig, Shaw (CR22) 2018; 19 Cantó, Gerhart-Hines, Feige, Lagouge, Noriega, Milne (CR28) 2009; 458 Jäger, Handschin, St-Pierre, Spiegelman (CR27) 2007; 104 Pasikanti, Esuvaranathan, Ho, Mahendran, Kamaraj, Wu (CR37) 2010; 9 Tran, Xiao, Agarwal, Duex, Theodorescu (CR5) 2021; 21 Ling, Zhang, Yuan, Ren, Zhang, Chen (CR46) 2014; 74 Schmidt, Patel, Kirsch, Lewis, Vander Heiden, Locasale (CR36) 2021; 71 Murray, Patterson, Perdew (CR42) 2014; 14 Vyas, Zaganjor, Haigis (CR13) 2016; 166 Lu, Zhu, Cai, Dong, Zhu, Tan (CR8) 2019; 19 CR26 Yang, Jing, Wang, Wang, Rodriguez, Wang (CR10) 2023; 2023 Mezrich, Fechner, Zhang, Johnson, Burlingham, Bradfield (CR41) 2010; 185 CR45 Hanahan, Weinberg (CR12) 2011; 144 Mesker, Junggeburt, Szuhai, de Heer, Morreau, Tanke (CR15) 2007; 29 Tilokani, Nagashima, Paupe, Prudent (CR31) 2018; 62 Lin, Wang, Wu, Jin, Ma, Liu (CR34) 2018; 480 Elia, Haigis (CR11) 2021; 3 Aran, Hu, Butte (CR17) 2017; 18 Opitz, Litzenburger, Sahm, Ott, Tritschler, Trump (CR23) 2011; 478 Yoshihara, Shahmoradgoli, Martínez, Vegesna, Kim, Torres-Garcia (CR16) 2013; 4 Porporato, Filigheddu, Pedro, Kroemer, Galluzzi (CR14) 2018; 28 Demichev, Messner, Vernardis, Lilley, Ralser (CR20) 2020; 17 Bordi, Nazio, Campello (CR32) 2017; 7 Pasikanti, Esuvaranathan, Hong, Ho, Mahendran, Raman Nee Mani (CR38) 2013; 12 YC Lee (7068_CR4) 2022; 19 RB Holmgaard (7068_CR44) 2013; 210 SP Zhang (7068_CR19) 2021; 417 V Demichev (7068_CR20) 2020; 17 IA Murray (7068_CR42) 2014; 14 MD Galsky (7068_CR2) 2020; 395 L Tran (7068_CR5) 2021; 21 Y Lin (7068_CR34) 2018; 480 M Timaner (7068_CR6) 2020; 60 S Srivastava (7068_CR40) 2010; 6 CA Opitz (7068_CR23) 2011; 478 PA Li (7068_CR29) 2017; 95 M Platten (7068_CR24) 2019; 18 W Lin (7068_CR9) 2019; 19 SH Lee (7068_CR35) 2021; 127 J Lu (7068_CR8) 2019; 19 S Vyas (7068_CR13) 2016; 166 VG Patel (7068_CR1) 2020; 70 PE Porporato (7068_CR14) 2018; 28 M Bordi (7068_CR32) 2017; 7 KK Pasikanti (7068_CR38) 2013; 12 GC Prendergast (7068_CR43) 2017; 77 A Lopez-Beltran (7068_CR3) 2024; 384 S Herzig (7068_CR22) 2018; 19 C Cantó (7068_CR28) 2009; 458 I Elia (7068_CR11) 2021; 3 K Yoshihara (7068_CR16) 2013; 4 GY Chen (7068_CR18) 2018; 1037 KK Pasikanti (7068_CR37) 2010; 9 M Zaccolo (7068_CR21) 2021; 73 S Jäger (7068_CR27) 2007; 104 D Aran (7068_CR17) 2017; 18 7068_CR26 7068_CR45 W Ling (7068_CR46) 2014; 74 PS Ward (7068_CR30) 2012; 21 L Tilokani (7068_CR31) 2018; 62 DR Schmidt (7068_CR36) 2021; 71 Y Shi (7068_CR7) 2017; 16 D Hanahan (7068_CR12) 2011; 144 Q Babar (7068_CR25) 2023; 1869 JD Mezrich (7068_CR41) 2010; 185 E Yang (7068_CR10) 2023; 2023 WE Mesker (7068_CR15) 2007; 29 Y Lu (7068_CR33) 2021; 12 BM Wittmann (7068_CR39) 2014; 9 |
References_xml | – ident: CR45 – volume: 6 start-page: 11 year: 2010 end-page: 20 ident: CR40 article-title: Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy publication-title: Cancer Biomark doi: 10.3233/CBM-2009-0115 – volume: 71 start-page: 333 year: 2021 end-page: 58 ident: CR36 article-title: Metabolomics in cancer research and emerging applications in clinical oncology publication-title: CA Cancer J Clin doi: 10.3322/caac.21670 – volume: 417 start-page: 126082 year: 2021 ident: CR19 article-title: Proteomic analysis reveals the mechanism of different environmental stress-induced tolerance of Pseudomonas aeruginosa to monochloramine disinfection publication-title: J Hazard Mater doi: 10.1016/j.jhazmat.2021.126082 – volume: 18 start-page: 379 year: 2019 end-page: 401 ident: CR24 article-title: Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-019-0016-5 – volume: 7 start-page: 81 year: 2017 ident: CR32 article-title: The close interconnection between mitochondrial dynamics and mitophagy in cancer publication-title: Front Oncol doi: 10.3389/fonc.2017.00081 – volume: 17 start-page: 41 year: 2020 end-page: 44 ident: CR20 article-title: DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput publication-title: Nat Methods doi: 10.1038/s41592-019-0638-x – volume: 12 start-page: 3865 year: 2013 end-page: 73 ident: CR38 article-title: Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry publication-title: J Proteome Res doi: 10.1021/pr4000448 – volume: 458 start-page: 1056 year: 2009 end-page: 60 ident: CR28 article-title: AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity publication-title: Nature doi: 10.1038/nature07813 – volume: 95 start-page: 2025 year: 2017 end-page: 9 ident: CR29 article-title: Mitochondrial biogenesis in neurodegeneration publication-title: J Neurosci Res doi: 10.1002/jnr.24042 – volume: 21 start-page: 104 year: 2021 end-page: 21 ident: CR5 article-title: Advances in bladder cancer biology and therapy publication-title: Nat Rev Cancer doi: 10.1038/s41568-020-00313-1 – volume: 19 start-page: 515 year: 2022 end-page: 33 ident: CR4 article-title: The dynamic roles of the bladder tumour microenvironment publication-title: Nat Rev Urol doi: 10.1038/s41585-022-00608-y – volume: 28 start-page: 265 year: 2018 end-page: 80 ident: CR14 article-title: Mitochondrial metabolism and cancer publication-title: Cell Res doi: 10.1038/cr.2017.155 – volume: 3 start-page: 21 year: 2021 end-page: 32 ident: CR11 article-title: Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism publication-title: Nat Metab doi: 10.1038/s42255-020-00317-z – volume: 2023 start-page: 7059289 year: 2023 ident: CR10 article-title: The role of mesenchymal stem cells and exosomes in tumor development and targeted antitumor therapies publication-title: Stem Cells Int doi: 10.1155/2023/7059289 – volume: 1869 start-page: 166746 year: 2023 ident: CR25 article-title: Targeting the tumor microenvironment: potential strategy for cancer therapeutics publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2023.166746 – volume: 60 start-page: 225 year: 2020 end-page: 37 ident: CR6 article-title: The multifaceted role of mesenchymal stem cells in cancer publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2019.06.003 – volume: 166 start-page: 555 year: 2016 end-page: 66 ident: CR13 article-title: Mitochondria and cancer publication-title: Cell doi: 10.1016/j.cell.2016.07.002 – volume: 21 start-page: 297 year: 2012 end-page: 308 ident: CR30 article-title: Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.02.014 – volume: 395 start-page: 1547 year: 2020 end-page: 57 ident: CR2 article-title: Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(20)30230-0 – volume: 16 start-page: 35 year: 2017 end-page: 52 ident: CR7 article-title: Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2016.193 – volume: 9 start-page: e115870 year: 2014 ident: CR39 article-title: Bladder cancer biomarker discovery using global metabolomic profiling of urine publication-title: PLoS ONE doi: 10.1371/journal.pone.0115870 – volume: 14 start-page: 801 year: 2014 end-page: 14 ident: CR42 article-title: Aryl hydrocarbon receptor ligands in cancer: friend and foe publication-title: Nat Rev Cancer doi: 10.1038/nrc3846 – volume: 19 start-page: 121 year: 2018 end-page: 35 ident: CR22 article-title: AMPK: guardian of metabolism and mitochondrial homeostasis publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2017.95 – volume: 480 start-page: 41 year: 2018 end-page: 6 ident: CR34 article-title: Association between obesity and bladder cancer recurrence: a meta-analysis publication-title: Clin Chim Acta doi: 10.1016/j.cca.2018.01.039 – volume: 127 start-page: 445 year: 2021 end-page: 53 ident: CR35 article-title: Tryptophan-kynurenine ratio as a biomarker of bladder cancer publication-title: BJU Int doi: 10.1111/bju.15205 – volume: 104 start-page: 12017 year: 2007 end-page: 22 ident: CR27 article-title: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0705070104 – volume: 19 start-page: 12 year: 2019 end-page: 7 ident: CR9 article-title: A novel protocol for isolation and culture of multipotent progenitor cells from human urine publication-title: J Orthop Transl – volume: 77 start-page: 6795 year: 2017 end-page: 811 ident: CR43 article-title: Discovery of IDO1 inhibitors: from bench to bedside publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-2285 – volume: 70 start-page: 404 year: 2020 end-page: 23 ident: CR1 article-title: Treatment of muscle-invasive and advanced bladder cancer in 2020 publication-title: CA Cancer J Clin doi: 10.3322/caac.21631 – volume: 74 start-page: 1576 year: 2014 end-page: 87 ident: CR46 article-title: Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-1656 – volume: 384 start-page: e076743 year: 2024 ident: CR3 article-title: Advances in diagnosis and treatment of bladder cancer publication-title: BMJ doi: 10.1136/bmj-2023-076743 – volume: 210 start-page: 1389 year: 2013 end-page: 402 ident: CR44 article-title: Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4 publication-title: J Exp Med doi: 10.1084/jem.20130066 – volume: 478 start-page: 197 year: 2011 end-page: 203 ident: CR23 article-title: An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor publication-title: Nature doi: 10.1038/nature10491 – volume: 185 start-page: 3190 year: 2010 end-page: 8 ident: CR41 article-title: An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells publication-title: J Immunol doi: 10.4049/jimmunol.0903670 – volume: 19 start-page: 187 year: 2019 end-page: 94 ident: CR8 article-title: Isolation and multipotential differentiation of mesenchymal stromal cell‑like progenitor cells from human bladder publication-title: Mol Med Rep – volume: 4 year: 2013 ident: CR16 article-title: Inferring tumour purity and stromal and immune cell admixture from expression data publication-title: Nat Commun doi: 10.1038/ncomms3612 – volume: 1037 start-page: 200 year: 2018 end-page: 10 ident: CR18 article-title: Simultaneous determination of tryptophan and its 31 catabolites in mouse tissues by polarity switching UHPLC-SRM-MS publication-title: Anal Chim Acta doi: 10.1016/j.aca.2018.02.026 – volume: 144 start-page: 646 year: 2011 end-page: 74 ident: CR12 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 29 start-page: 387 year: 2007 end-page: 98 ident: CR15 article-title: The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage publication-title: Cell Oncol – volume: 18 year: 2017 ident: CR17 article-title: xCell: digitally portraying the tissue cellular heterogeneity landscape publication-title: Genome Biol doi: 10.1186/s13059-017-1349-1 – volume: 62 start-page: 341 year: 2018 end-page: 60 ident: CR31 article-title: Mitochondrial dynamics: overview of molecular mechanisms publication-title: Essays Biochem doi: 10.1042/EBC20170104 – volume: 73 start-page: 278 year: 2021 end-page: 309 ident: CR21 article-title: Subcellular organization of the cAMP signaling pathway publication-title: Pharm Rev doi: 10.1124/pharmrev.120.000086 – ident: CR26 – volume: 12 year: 2021 ident: CR33 article-title: Diabetes mellitus and obesity as risk factors for bladder cancer prognosis: a systematic review and meta-analysis publication-title: Front Endocrinol doi: 10.3389/fendo.2021.699732 – volume: 9 start-page: 2988 year: 2010 end-page: 95 ident: CR37 article-title: Noninvasive urinary metabonomic diagnosis of human bladder cancer publication-title: J Proteome Res doi: 10.1021/pr901173v – volume: 417 start-page: 126082 year: 2021 ident: 7068_CR19 publication-title: J Hazard Mater doi: 10.1016/j.jhazmat.2021.126082 – volume: 29 start-page: 387 year: 2007 ident: 7068_CR15 publication-title: Cell Oncol – volume: 21 start-page: 104 year: 2021 ident: 7068_CR5 publication-title: Nat Rev Cancer doi: 10.1038/s41568-020-00313-1 – volume: 19 start-page: 12 year: 2019 ident: 7068_CR9 publication-title: J Orthop Transl – volume: 28 start-page: 265 year: 2018 ident: 7068_CR14 publication-title: Cell Res doi: 10.1038/cr.2017.155 – volume: 3 start-page: 21 year: 2021 ident: 7068_CR11 publication-title: Nat Metab doi: 10.1038/s42255-020-00317-z – volume: 9 start-page: e115870 year: 2014 ident: 7068_CR39 publication-title: PLoS ONE doi: 10.1371/journal.pone.0115870 – volume: 60 start-page: 225 year: 2020 ident: 7068_CR6 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2019.06.003 – volume: 19 start-page: 187 year: 2019 ident: 7068_CR8 publication-title: Mol Med Rep – volume: 21 start-page: 297 year: 2012 ident: 7068_CR30 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.02.014 – volume: 18 year: 2017 ident: 7068_CR17 publication-title: Genome Biol doi: 10.1186/s13059-017-1349-1 – volume: 6 start-page: 11 year: 2010 ident: 7068_CR40 publication-title: Cancer Biomark doi: 10.3233/CBM-2009-0115 – volume: 71 start-page: 333 year: 2021 ident: 7068_CR36 publication-title: CA Cancer J Clin doi: 10.3322/caac.21670 – volume: 166 start-page: 555 year: 2016 ident: 7068_CR13 publication-title: Cell doi: 10.1016/j.cell.2016.07.002 – volume: 7 start-page: 81 year: 2017 ident: 7068_CR32 publication-title: Front Oncol doi: 10.3389/fonc.2017.00081 – volume: 144 start-page: 646 year: 2011 ident: 7068_CR12 publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 9 start-page: 2988 year: 2010 ident: 7068_CR37 publication-title: J Proteome Res doi: 10.1021/pr901173v – volume: 70 start-page: 404 year: 2020 ident: 7068_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21631 – ident: 7068_CR26 doi: 10.3390/biom10020347 – volume: 127 start-page: 445 year: 2021 ident: 7068_CR35 publication-title: BJU Int doi: 10.1111/bju.15205 – volume: 458 start-page: 1056 year: 2009 ident: 7068_CR28 publication-title: Nature doi: 10.1038/nature07813 – volume: 12 start-page: 3865 year: 2013 ident: 7068_CR38 publication-title: J Proteome Res doi: 10.1021/pr4000448 – volume: 19 start-page: 515 year: 2022 ident: 7068_CR4 publication-title: Nat Rev Urol doi: 10.1038/s41585-022-00608-y – volume: 16 start-page: 35 year: 2017 ident: 7068_CR7 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2016.193 – volume: 2023 start-page: 7059289 year: 2023 ident: 7068_CR10 publication-title: Stem Cells Int doi: 10.1155/2023/7059289 – volume: 1037 start-page: 200 year: 2018 ident: 7068_CR18 publication-title: Anal Chim Acta doi: 10.1016/j.aca.2018.02.026 – volume: 17 start-page: 41 year: 2020 ident: 7068_CR20 publication-title: Nat Methods doi: 10.1038/s41592-019-0638-x – volume: 4 year: 2013 ident: 7068_CR16 publication-title: Nat Commun doi: 10.1038/ncomms3612 – volume: 95 start-page: 2025 year: 2017 ident: 7068_CR29 publication-title: J Neurosci Res doi: 10.1002/jnr.24042 – volume: 384 start-page: e076743 year: 2024 ident: 7068_CR3 publication-title: BMJ doi: 10.1136/bmj-2023-076743 – volume: 104 start-page: 12017 year: 2007 ident: 7068_CR27 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0705070104 – volume: 480 start-page: 41 year: 2018 ident: 7068_CR34 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2018.01.039 – volume: 210 start-page: 1389 year: 2013 ident: 7068_CR44 publication-title: J Exp Med doi: 10.1084/jem.20130066 – volume: 185 start-page: 3190 year: 2010 ident: 7068_CR41 publication-title: J Immunol doi: 10.4049/jimmunol.0903670 – ident: 7068_CR45 doi: 10.1200/JCO.2019.37.7_suppl.358 – volume: 14 start-page: 801 year: 2014 ident: 7068_CR42 publication-title: Nat Rev Cancer doi: 10.1038/nrc3846 – volume: 395 start-page: 1547 year: 2020 ident: 7068_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(20)30230-0 – volume: 1869 start-page: 166746 year: 2023 ident: 7068_CR25 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2023.166746 – volume: 19 start-page: 121 year: 2018 ident: 7068_CR22 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2017.95 – volume: 62 start-page: 341 year: 2018 ident: 7068_CR31 publication-title: Essays Biochem doi: 10.1042/EBC20170104 – volume: 73 start-page: 278 year: 2021 ident: 7068_CR21 publication-title: Pharm Rev doi: 10.1124/pharmrev.120.000086 – volume: 12 year: 2021 ident: 7068_CR33 publication-title: Front Endocrinol doi: 10.3389/fendo.2021.699732 – volume: 77 start-page: 6795 year: 2017 ident: 7068_CR43 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-2285 – volume: 74 start-page: 1576 year: 2014 ident: 7068_CR46 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-1656 – volume: 18 start-page: 379 year: 2019 ident: 7068_CR24 publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-019-0016-5 – volume: 478 start-page: 197 year: 2011 ident: 7068_CR23 publication-title: Nature doi: 10.1038/nature10491 |
SSID | ssj0000330256 |
Score | 2.4288585 |
Snippet | Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and mechanism... Abstract Mesenchymal stem cells (MSCs) in tumor microenvironment (TME) are crucial for the initiation, development, and metastasis of cancer. The impact and... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 688 |
SubjectTerms | 692/699/67/327 692/699/67/589/1336 Aged Animals Antibodies Autophagy Biochemistry Biomedical and Life Sciences Bladder cancer Cell Biology Cell Culture Cell Line, Tumor Cell Movement Cell Proliferation Cell size Coculture Techniques Disease Progression Energy Metabolism Female Humans Immunology Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism Kynurenine - metabolism Life Sciences Male Mesenchymal stem cells Mesenchymal Stem Cells - metabolism Metastases Mice Mice, Inbred BALB C Mice, Nude Middle Aged Mitochondria Mitochondria - metabolism Mitochondrial Dynamics Molecular modelling Stem cell transplantation Stem cells Stroma Tryptophan Tumor Microenvironment Tumors Urinary Bladder Neoplasms - genetics Urinary Bladder Neoplasms - metabolism Urinary Bladder Neoplasms - pathology |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUMiltE3auk2LArm1JrYettxbExpCITk1kJvQyySQtYPXe8h_6I_ujOTd7iZ9XHJdSyA037xWM98QclhwaY3wPm9YsLmQJc-tDzw3onZKSsld7PA-v6jOLsX3K3m1NuoLa8ISPXC6uCPHglNe1Q58l2gBX8YUyqIfVEGWVQyNwOetJVPRBkOaDs586pIpuDqai1Jgvw4TOaC8Ai3f8ESRsP9PUebjYskHL6bREZ2-IM-nCJJ-TSd_SbZC94o8SzMl73fJz3PsJ3LX9zNYhCzNFP-bn9Objo6LWT_QGZbgrfW3faF-iMUZtG-pvUVLNFCHYBhorN5KzB10mugD-8cebGbnEbrUp4n2c2o6T0NsJMRdPpHS7pHL028_Ts7yaeRC7qQox9xX0vK2DGAHbGB1XbUQPhbSVcoVwjXOhsoVLfMQqBkevKgbCBAbw62QlgWIvV6T7a7vwltCrQisNK2BjNGDoVBNEUTwnDNIiyEIazJSLq9fu4mPHMdi3Or4Ls6VTiLTIDIdRaZhz6fVnrvExvHP1cco1dVKZNKOPwC-9IQv_T98ZWR_iQk9qfdcQ0xcg-0CY5eRg9VnUEyUqOlCv0hrJPLrq4y8SRBanYQ3-CAti4yoDXBtHHXzS3dzHcm_IX9FVj2Rkc9LHP4-19_v4t1T3MV7ssOiAjVgXPfJ9jgswgeIyUb7MarfLzMVM5M priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LbtUwELWgCIkN4k2gICOxg6hObCcOGwSIqkIqKyrdneVXaKXepCS5i_4DH82M45tyeXSb2JKTOTM-fswZQl4zLq0R3udNGWwuZMFz6wPPjaidklJyFzO8j79WRyfiy0qu0obbmK5VbmNiDNS-d7hHfgA0pAa4AL7eX_zIsWoUnq6mEho3yS2ULkNU16t62WNhsFiHKT3lyjCuDkZRCMzaKUUOWK_A13fmoyjb_y-u-feVyT_OTeN0dHiP3E08kn6YDX-f3AjdA3J7rix5-ZD8PMasInd6uYZGqNVMcYd-pGcdnTbrfqBrvIj3W5bbO-qHeEWD9i215xiPBuoQEgONd7hm_Q6a6vpA_6mHyNl5BDD1c137kZrO0xDTCbGXn6VpH5GTw8_fPh3lqfBC7qQoptxX0vK2CBANbCjrumqBRDLpKuWYcI2zoXKsLT3QNcODF3UDNLEx3AppywAM7DHZ6_ouPCXUilAWpjWwbvQQLlTDggie8xIWx0DFmowU29-vXVIlx-IY5zqejnOlZ5NpMJmOJtPQ583S52LW5Li29Ue06tIS9bTjg374rpN7alcGp7yqHTAk0UIUM4Ypi2xLBVlUJiP7W0zo5OSjvoJkRl4tr8E90aKmC_1mbiNRZV9l5MkMoWUkvMFjackyonbAtTPU3Tfd2WmUAIdVLGrriYy83eLwalz__xfPrv-M5-ROGV2jgeC5T_amYRNeAOea7MvoWL8AhNkrWQ priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEB5qi-CLWG-NtrKCbxpM9pJsfDuWlnKgvmihb8veYgs9ieTkPPQ_-KOd3Vz0aBV8TWZgyVz22-zMNwBvMiaM5s6lFfUm5SJnqXGepZqXVgohmI0d3uefirMLvrwUlztAp16YWLQfKS1jmp6qw96vec5Duw3lKTppgUF6D_YCVTv69t5isfy8nP-sZHhEx4187JDJmLxDeWsXimT9dyHMPwslf7stjZvQ6SN4OKJHshjWuw87vnkM94d5krdP4Pt56CWyV7crFAoMzST8l1-T64b0m1XbkVUov_ult-0DcV0szCBtTcxNyEIdscEROhIrtwbWDjJO80H9vsV82bjgtsQN0-zXRDeO-NhEGLTcQEj7FC5OT74cn6XjuIXUCp73qSuEYXXuMQcYT8uyqBE6ZsIW0mbcVtb4wmY1dQjSNPOOlxWCw0ozw4WhHnHXM9ht2sYfADHc01zXGk-LDpOErDLPvWOM4pEYAViVQD59fmVHLvIwEuNGxTtxJtVgMoUmU9FkCnXezjrfBiaOf0p_DFadJQOLdnzQdl_V6FXKUm-lk6VFXMRrzF1aZ9IEjCW9yAudwOHkE2oM7bVCPFxi3sJEl8Dr-TUGZbCobny7GWRE4NaXCTwfXGheCavCZbTIEpBbzrW11O03zfVVJP7Gs2tg1OMJvJv88Oe6_v4tXvyf-Et4QGOoVJhCD2G37zb-CJFXb16NofYDkbsqeg priority: 102 providerName: Springer Nature |
Title | Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production |
URI | https://link.springer.com/article/10.1038/s41419-024-07068-9 https://www.ncbi.nlm.nih.gov/pubmed/39304650 https://www.proquest.com/docview/3107319787 https://www.proquest.com/docview/3107506628 https://pubmed.ncbi.nlm.nih.gov/PMC11415494 https://doaj.org/article/c2ec8d87c0814f578aa08b74158e516a |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9NAFB72guCLeDe6lhF802gyl2QiiHRLl6XQRdRC38LcsrvQJpqmYF_8Bf5oz0ySarWKLwkkM2GYc5nvZOZ8B6HnEeVKMmPCjFgVMh7TUBlLQ8lSLTjnVPsM7-lFcj5jkzmfH6C-3FE3gau9oZ2rJzWrF6--ftm8A4N_26aMi9crFjOXikNYCAqcgAEfomNYmVJX0WDawX3vmSF4J76gK4kYhE5CZF0ezf7P7KxVntJ_Hw798zjlb3uqfqk6u41udRgTD1uluIMObHkX3WirTm7uoe9Tl3GkrzZLaOR4nLH7e7_C1yVu1suqxkt3SO-XDLg32NT--AauCqwWzlfVWDt1qbE_39Vye-Cu5g_0byqY2NI45camrXm_wrI02PpUQ9fLtLS199HsbPxpdB52RRlCzVnchCbhihaxBU-hLEnTpACAGXGdCB0xnWllEx0VxACUk9QalmYAITNJFeOKWEBnD9BRWZX2EcKKWRLLQkJMacCViCyyzBpKCQTOANOyAMX99Oe6Yyx3hTMWud85pyJvRZaDyHIvshz6vNj2-dzydfyz9amT6ral49r2D6r6Mu9MN9fEamFEqgE9sQI8nJSRUA6JCcvjRAbopNeJvNffHFBzCt4N3GGAnm1fg-k6icrSVuu2DXcM_CJAD1sV2o6EZm7LmkcBEjvKtTPU3Tfl9ZWnB4cI1_HusQC97PXw57j-PheP_2OcT9BN4u0jA-96go6aem2fAihr1AAdpvN0gI6Hw8nHCdxPxxfvP8DTUTIa-B8dA2-L7vpt_AO5FTl1 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLVKEYIN4lkCBYwEK4iaxHbiICHEq5rSTlet1J3xK7RSJymZGaH5B76Fb-ReJ5kyPLrrdmJHntxzT47j-yDkecKE0dy5uMy8iblIWWycZ7HmhZVCCGZDhvd4Px8d8s9H4miN_BxyYTCscuDEQNSusfiNfAtkSAFwAXy9PfsWY9coPF0dWmh0sNj1i--wZZu-2fkI9n2RZdufDj6M4r6rQGwFT2exy4VhVeoB6sZnRZFXoJASYXNpE25La3xukypzoEU0844XJWigUjPDhck8yAu47xVyleOCwH-Ko2L5TSdhDCVEn5uTMLk15SnHLKGMx-BbOXDLyvsvtAn4l7b9O0Tzj3Pa8PrbvkVu9rqVvuuAdpus-foOudZ1slzcJT_GmMVkjxcTGIS1oSmeCEzpSU1n80nT0gkG_v2WVfeaujaEhNCmouYU-a-lFiHY0hAz1tULoX0fIZg_a4Cpa4cOQ92i1nDHKdW1oz6kL-Is15XCvUcOL8Uk98l63dT-AaGG-yzVlYZ9qgN6kmXiuXeMZbAZB-lXRiQdHr-yfRV0bMZxqsJpPJOqM5kCk6lgMgVzXi7nnHU1QC4c_R6tuhyJ9bvDD037VfV0oGzmrXSysKDIeAWsqXUiDao76UWa64hsDphQPalM1bkLROTZ8jLQAVpU176Zd2MEVvWXEdnoILRcCSvxGFwkEZEr4FpZ6uqV-uQ4lByHXTPW8uMReTXg8Hxd_38WDy_-G0_J9dHBeE_t7ezvPiI3suAmJRD3JlmftXP_GPTezDwJTkbJl8v26l8MMmeY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJxAviDuBAUaCJ4iaxHYuSAgxtmpjrJoQk_ZmfAubtCYjbYX6H_hF_DrOcZKOctnbXhs7cnO-8-VzfC6EPI-Y0IpbGxaJ0yEXMQu1dSxUPDO5EIIZn-G9P053DvmHI3G0Rn72uTAYVtlzoidqWxv8Rj4EGZIBXABfw7ILizjYGr09-xZiByk8ae3babQQ2XOL77B9m77Z3QJbv0iS0fbn9zth12EgNILHs9CmQrMydgB77ZIsS0tQS5EwaW4ibgqjXWqiMrGgSxRzlmcF6KFCMc2FThxIDbjvFbKe4a5oQNY3t8cHn5ZfeCLGUFB0mToRy4dTHnPMGUp4CJ6WAtOsvA1904B_Kd2_Azb_OLX1L8PRTXKjU7H0XQu7W2TNVbfJ1bav5eIO-bGPOU3meDGBQVgpmuL5wJSeVHQ2n9QNnWAY4G85dq-pbXyACK1Lqk-RDRtqEJAN9RFkbfUQ2nUVgvmzGni7sug-1C4qBXecUlVZ6nwyI86ybWHcu-TwUoxyjwyqunIPCNXcJbEqFdjHAlnlReS4s4wlsDUHIVgEJO4fvzRdTXRszXEq_dk8y2VrMgkmk95kEua8XM45ayuCXDh6E626HInVvP0PdfNVduQgTeJMbvPMgD7jJXCoUlGuUevlTsSpCshGjwnZUcxUnjtEQJ4tLwM5oEVV5ep5O0Zgjf88IPdbCC1Xwgo8FBdRQPIVcK0sdfVKdXLsC5DDHhor-_GAvOpxeL6u_z-Lhxf_jafkGni0_Lg73ntErifeSwpg8Q0ymDVz9xjE30w_6byMki-X7di_APu3bTM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+stem+cells+in+tumor+microenvironment%3A+drivers+of+bladder+cancer+progression+through+mitochondrial+dynamics+and+energy+production&rft.jtitle=Cell+death+%26+disease&rft.au=Yang%2C+Enguang&rft.au=Jing%2C+Suoshi&rft.au=Wang%2C+Fang&rft.au=Wang%2C+Hanzhang&rft.date=2024-09-20&rft.issn=2041-4889&rft.eissn=2041-4889&rft.volume=15&rft.issue=9&rft.spage=688&rft_id=info:doi/10.1038%2Fs41419-024-07068-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |